Conceptus CEO hired
This article was originally published in The Gray Sheet
Former Bausch & Lomb President, Americas, Mark Sieczkarek, 48, is appointed president, CEO and board member of the Essure non-incisional birth control company, effective April 17. Former president and CEO Steven Bacich will become the firm's chief technology officer. The San Carlos, Calif. firm says Sieczkarek's experience in overseeing the launch of B&L's Zyoptix laser for LASIK eye surgery will serve him in marketing Essure, approved last November (1"The Gray Sheet" Nov. 11, 2002, p. 16)...
You may also be interested in...
FDA's approval of Conceptus' Essure non-incisional permanent birth control device includes a requirement that the company document the placement failure rate with newly trained physicians and identify factors associated with the failure, the agency notes in a Nov. 4 "talk paper" announcing the approval
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.